Stat Proteins Control Lymphocyte Proliferation by Regulating p27^Kip1 Expression

REFERENCES

• Agrawal, D., P. Hauser, F. McPherson, F. Dong, A. Garcia, and W. J. Pledger 1996. Repression of p27Kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells. Mol. Cell. Biol. 16: 4327–4336.
   PubMedGoogle Scholar
• Blanchard, D. A., M. T. Affredou, and A. Vazquez 1997. Modulation of p27Kip1 cyclin-dependent kinase inhibitor expression during IL-4 mediated human B cell activation. J. Immunol. 158: 3054–3061.
   PubMedGoogle Scholar
• Broome, H. E., C. M. Dargan, S. Krajewski, and J. C. Reed 1995. Expression of bcl-2, bcl-x and bax after T cell activation and IL-2 withdrawal. J. Immunol. 155: 2311–2317.
   PubMed Web of Science ®Google Scholar
• Brugarolos, J., C. Chandrasekaran, J. I. Gordon, D. Beach, T. Lacks, and G. J. Hannon 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377: 552–557.
   PubMed Web of Science ®Google Scholar
• Carlesso, N., D. A. Frank, and J. D. Griffen 1996. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J. Exp. Med. 183: 811–820.
   PubMed Web of Science ®Google Scholar
• Chin, Y. E., M. Kitagawa, W.-C. S. Su, Z.-H. You, Y. Iwamoto, and X.-Y. Fu 1996. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21Waf1/Cip1 mediated by Stat1. Science 272: 719–722.
   PubMed Web of Science ®Google Scholar
• Damen, J. E., H. Wakao, A. Miyajima, J. Krosl, R. K. Humphries, R. L. Cutler, and G. Krystal 1995. Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation. EMBO J. 14: 5557–5568.
   PubMed Web of Science ®Google Scholar
• Danial, N. N., A. Pernis, and P. B. Rothman 1995. Jak-Stat signaling induced by the v-abl oncogene. Science 269: 1875–1877.
   PubMed Web of Science ®Google Scholar
• Deng, C., P. Zhang, J. W. Harper, S. J. Elledge, and P. Leder 1995. Mice lacking p21Cip1/Waf1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675–684.
   PubMed Web of Science ®Google Scholar
• Deng, G., and E. R. Podack 1993. Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2 mediated gene transcription and deregulated expression of the protooncogene bcl-2. Proc. Natl. Acad. Sci. USA 90: 2189–2193.
   PubMed Web of Science ®Google Scholar
• Deutsch, H. H. J., K. Koettnitz, J. Chung, and F. S. Kalthoff 1995. Distinct sequence motifs within the cytoplasmic domain of the human IL-4 receptor differentially regulate apoptosis inhibition and cell growth control. J. Immunol. 154: 3696–3703.
   PubMedGoogle Scholar
• Dokter, W. H., P. Borger, D. Hendricks, I. van der Horst, M. R. Halie, and E. Vellenga 1992. Interleukin-4 (IL-4) receptor expression on human T cells is affected by different intracellular signaling pathways and by IL-4 at transcriptional and posttranscriptional levels. Blood 80: 2721–2728.
   PubMed Web of Science ®Google Scholar
• Fero, M. L., M. Rivkin, M. Tasch, P. Porter, C. E. Carow, E. Firpo, K. Polyak, L.-H. Tsai, V. Broudy, R. M. Perlmutter, K. Kaushansky, and J. M. Roberts 1996. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27Kip1-deficient mice. Cell 85: 733–744.
   PubMed Web of Science ®Google Scholar
• Firpo, E. J., A. Koff, M. J. Solomon, and J. M. Roberts 1994. Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol. Cell. Biol. 14: 4889–4901.
   PubMed Web of Science ®Google Scholar
• Fujii, H., Y. Nakagawa, U. Schindler, A. Kawahara, H. Mori, F. Gouilleux, B. Groner, J. N. Ihle, Y. Minami, and T. Miyazaki 1995. Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for proliferative signal transmission. Proc. Natl. Acad. Sci. USA 92: 5482–5486.
   PubMed Web of Science ®Google Scholar
• Giri, J. G., M. Ahdieh, J. Eisenman, K. Shanebeck, K. Grabstein, S. Kumaki, A. Namen, L. S. Park, D. Cosman, and D. Anderson 1994. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 13: 2822–2830.
   PubMed Web of Science ®Google Scholar
• Hengst, L., and S. I. Reed 1996. Translational control of p27Kip1 accumulation during the cell cycle. Science 271: 1861–1864.
   PubMed Web of Science ®Google Scholar
• Hilton, D. J., J.-G. Zhang, D. Metcalf, W. S. Alexander, N. A. Nicola, and T. A. Wilson 1996. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc. Natl. Acad. Sci. USA 93: 497–501.
   PubMed Web of Science ®Google Scholar
• Hou, J., U. Schindler, W. J. Henzel, T. C. Ho, M. Brasseur, and S. L. McKnight 1994. An interleukin-4-induced transcription factor: IL-4 Stat. Science 265: 1701–1706.
   PubMed Web of Science ®Google Scholar
• Johnston, J. A., M. Kawamura, R. A. Kirken, Y.-Q. Chen, T. B. Blake, K. Shibuya, J. R. Ortaldo, D. W. McVicar, and J. J. O’Shea 1994. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature 370: 151–153.
   PubMed Web of Science ®Google Scholar
• Kaplan, M. H., U. Schindler, S. T. Smiley, and M. J. Grusby 1996. Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity 4: 313–319.
   PubMed Web of Science ®Google Scholar
• Kaplan, M. H., Y.-L. Sun, T. Hoey, and M. J. Grusby 1996. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382: 174–177.
   PubMed Web of Science ®Google Scholar
• Keegan, A. D., K. Nelms, M. White, L.-M. Wang, J. H. Pierce, and W. E. Paul 1994. An IL-4 receptor region containing an insulin receptor motif is important for IL-4 mediated IRS-1 phosphorylation and cell growth. Cell 76: 811–820.
   PubMed Web of Science ®Google Scholar
• Kiyokawa, H., R. D. Kineman, K. O. Manova-Todorova, V. C. Soares, E. S. Hoffman, M. Ono, D. Khanam, A. C. Hayday, L. A. Frohman, and A. Koff 1996. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27Kip1. Cell 85: 721–732.
   PubMed Web of Science ®Google Scholar
• Klemsz, M. J., L. B. Justement, E. Palmer, and J. C. Cambier 1989. Induction of c-fos and c-myc expression during B cell activation by IL-4 and immunoglobulin binding ligands. J. Immunol. 143: 1032–1039.
   PubMed Web of Science ®Google Scholar
• Kobayashi, K., J. Phuchareon, K. Inada, Y. Tomita, T. Koizumi, M. Hatano, S. Miyatake, and T. Tokuhisa 1997. Overexpression of c-fos inhibits down-regulation of a cyclin-dependent kinase-2 inhibitor p27Kip1 in splenic B cells activated by surface Ig cross-linking. J. Immunol. 158: 2050–2056.
   PubMedGoogle Scholar
• Kondo, M., T. Takeshita, M. Higuchi, M. Nakamura, T. Sudo, S.-I. Nishikawa, and K. Sugamura 1994. Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes. Science 263: 1453–1454.
   PubMed Web of Science ®Google Scholar
• Kotanides, H., and N. C. Reich 1993. Requirement of tyrosine phosphorylation for rapid activation of a DNA binding factor by IL-4. Science 262: 1265–1267.
   PubMedGoogle Scholar
• Kwon, T. K., M. A. Buchholz, P. Ponsalle, F. J. Chrest, and A. A. Nordin 1997. The regulation of p27Kip1 expression following the polyclonal activation of murine Go T cells. J. Immunol. 158: 5642–5648.
   PubMed Web of Science ®Google Scholar
• Luo, Y., S. O. Marx, H. Kiyokawa, A. Koff, J. Massague, and A. R. Marks 1996. Rapamycin resistance tied to defective regulation of p27Kip1. Mol. Cell. Biol. 16: 6744–6751.
   PubMed Web of Science ®Google Scholar
• Matsumura, I., J. Ishikawa, K. Nakajima, K. Oritani, Y. Tomiyama, J.-I. Miyagawa, T. Kato, H. Miyazaki, Y. Matsuzawa, and Y. Kanakura 1997. Thrombopoietin-induced differentiation of human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21WAF1/Cip1 by STAT5. Mol. Cell. Biol. 17: 2933–2943.
   PubMed Web of Science ®Google Scholar
• Matsuoka, S., M. C. Edwards, C. Bai, S. Parker, P. Zhang, A. Baldini, J. W. Harper, and S. J. Elledge 1995. p57Kip2, a structurally distinct member of the p21Cip1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9: 650–662.
   PubMed Web of Science ®Google Scholar
• Meur, S. C., and K. H. M. zum Buschenfelde 1986. T cell receptor triggering induces responsiveness to interleukin 1 and interleukin 2 but does not lead to proliferation. J. Immunol. 136: 4106–4112.
   PubMedGoogle Scholar
• Migone, T.-S., J.-X. Lin, A. Cereseto, J. C. Mulloy, J. J. O’Shea, G. Franchini, and W. J. Leonard 1995. Constitutively activated Jak-Stat pathway in T cells transformed with HTLV-I. Science 269: 79–81.
   PubMed Web of Science ®Google Scholar
• Millard, S. S., J. S. Yan, H. Nguyen, M. Pagano, H. Kiyokawa, and A. Koff 1997. Enhanced ribosomal association of p27Kip1 mRNA is a mechanism contributing to accumulation during growth arrest. J. Biol. Chem. 272: 7093–7098.
   PubMedGoogle Scholar
• Miyazaki, T., A. Kawahara, H. Fujii, Y. Nakagawa, Y. Minami, Z.-J. Liu, I. Oishi, O. Silvennoinen, B. A. Witthuhn, J. N. Ihle, and T. Taniguchi 1994. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science 266: 1045–1047.
   PubMed Web of Science ®Google Scholar
• Miyazaki, T., Z.-J. Liu, A. Kawahara, Y. Minami, K. Yamada, Y. Tsujimoto, E. L. Barsoumian, R. M. Perlmutter, and T. Taniguchi 1995. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc and lck cooperate in hematopoietic cell proliferation. Cell 81: 223–231.
   PubMed Web of Science ®Google Scholar
• Mui, A. L.-F., H. Wakao, T. Kinoshita, T. Kitamura, and A. Miyajima 1996. Suppression of interleukin-3-induced gene expression by a c-terminal truncated Stat5: role of Stat5 in proliferation. EMBO J. 15: 2425–2433.
   PubMed Web of Science ®Google Scholar
• Nakayama, K., N. Ishida, M. Shirane, A. Inomata, T. Inoue, N. Shishido, I. Horii, D. Y. Loh, and K.-I. Nakayama 1996. Mice lacking p27Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia and pituitary tumors. Cell 85: 707–720.
   PubMed Web of Science ®Google Scholar
• Noguchi, M., Y. Nakamura, S. M. Russell, S. F. Ziegler, M. Tsang, X. Cao, and W. J. Leonard 1993. Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. Science 262: 1877–1880.
   PubMed Web of Science ®Google Scholar
• Nourse, J., E. Firpo, W. M. Flanagan, S. Coats, K. Polyak, M.-H. Lee, J. Massague, G. R. Crabtree, and J. M. Roberts 1994. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372: 570–573.
   PubMed Web of Science ®Google Scholar
• Pagano, M., S. W. Tam, A. M. Theodoras, P. Beer-Romero, G. del Sal, V. Chau, P. R. Yew, G. F. Draetta, and M. Rolfe 1995. Role of the ubiquitin-proteosome pathway in regulating the abundance of the cyclin-dependent kinase inhibitor p27. Science 269: 682–685.
   PubMed Web of Science ®Google Scholar
• Parker, S. B., G. Eichele, P. Zhang, A. Rawls, A. T. Sands, A. Bradley, E. N. Olsen, J. W. Harper, and S. J. Elledge 1995. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 267: 1024–1027.
   PubMed Web of Science ®Google Scholar
• Pernis, A., B. Witthuhn, A. D. Keegan, K. Nelms, E. Garfein, J. N. Ihle, W. E. Paul, J. H. Pierce, and P. Rothman 1995. Interleukin 4 signals through two related pathways. Proc. Natl. Acad. Sci. USA 92: 7971–7975.
   PubMed Web of Science ®Google Scholar
• Pruett, W., Y. Yuan, E. Rose, A. G. Batzer, N. Harada, and E. Y. Skolnik 1995. Association between GRB2/Sos and insulin receptor substrate 1 is not sufficient for activation of extracellular signal-regulated kinases by interleukin-4: implications for Ras activation by insulin. Mol. Cell. Biol. 15: 1778–1785.
   PubMedGoogle Scholar
• Quelle, F. W., K. Shimoda, W. Thierfelder, C. Fischer, A. Kim, S. M. Ruben, J. L. Cleveland, J. H. Pierce, A. D. Keegan, K. Nelms, W. E. Paul, and J. N. Ihle 1995. Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol. Cell. Biol. 15: 3336–3343.
   PubMed Web of Science ®Google Scholar
• Quelle, F. W., D. Wang, T. Nosaka, W. E. Thierfelder, D. Stravopodis, Y. Weinstein, and J. N. Ihle 1996. Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Mol. Cell. Biol. 16: 1622–1631.
   PubMed Web of Science ®Google Scholar
• Russell, S. M., J. A. Johnston, M. Noguchi, M. Kawamura, C. M. Bacon, M. Friedmann, M. Berg, D. W. McVicar, B. A. Witthuhn, O. Silvennoinen, A. S. Goldman, F. C. Schmalsteig, J. N. Ihle, J. J. O’Shea, and W. J. Leonard 1994. Interaction of IL-2Rβ and γc chains with Jak1 and Jak 3: implications for XSCID and XCID. Science 266: 1042–1045.
   PubMed Web of Science ®Google Scholar
• Ryan, J. J., L. J. McReynolds, A. Keegan, L.-H. Wang, E. Garfein, P. Rothman, K. Nelms, and W. E. Paul 1996. Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor. Immunity 4: 123–132.
   PubMedGoogle Scholar
• Schindler, C., H. Kashleva, A. Pernis, R. Pine, and P. Rothman 1994. STF-IL-4: a novel IL-4 induced signal transducing factor. EMBO J. 13: 1350–1356.
   PubMedGoogle Scholar
• Schindler, U., P. Wu, M. Rothe, M. Brasseur, and S. L. McKnight 1995. Components of a Stat recognition code: evidence for two layers of molecular selectivity. Immunity 2: 689–697.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., and J. M. Roberts 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9: 1149–1163.
   PubMed Web of Science ®Google Scholar
• Shimoda, K., J. van Deursen, M. Y. Sangster, S. R. Sarawar, R. T. Carson, R. A. Tripp, C. Chu, F. W. Quelle, T. Nosaka, D. A. A. Vignali, P. C. Doherty, G. Grosveld, W. E. Paul, and J. N. Ihle 1996. Lack of IL-4 induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380: 630–633.
   PubMed Web of Science ®Google Scholar
• Sun, X. L., L.-M. Wang, Y. Zhang, L. Yenush, M. G. J. Myers, E. Glasheen, W. S. Lane, J. H. Pierce, and M. F. White 1995. Role of IRS-2 in insulin and cytokine signalling. Nature 377: 173–177.
   PubMed Web of Science ®Google Scholar
• Takeda, K., T. Tanaka, W. Shi, M. Matsumoto, M. Minami, S.-I. Kashiwamura, K. Nakanishi, N. Yoshido, T. Kishimoto, and S. Akira 1996. Essential role of Stat6 in IL-4 signalling. Nature 380: 627–630.
   PubMed Web of Science ®Google Scholar
• Takeshita, T., H. Asao, K. Ohtani, N. Ishii, S. Kumaki, N. Tanaka, H. Munakata, M. Nakamura, and K. Sugamura 1992. Cloning of the gamma chain of the human IL-2 receptor. Science 257: 379–382.
   PubMed Web of Science ®Google Scholar
• Thierfelder, W. E., J. M. van Deursen, K. Yamamoto, R. A. Tripp, S. R. Sarawar, R. T. Carson, M. Y. Sangster, D. A. A. Vignali, P. C. Doherty, G. C. Grosveld, and J. N. Ihle 1996. Requirement for Stat4 in interleukin-12 mediated responses of natural killer and T cells. Nature 382: 171–174.
   PubMed Web of Science ®Google Scholar
• Vella, A., T. K. Teague, J. Ihle, J. Kappler, and P. Marrack 1997. Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: Stat6 is probably not required for the effect of IL-4. J. Exp. Med. 186: 325–330.
   PubMed Web of Science ®Google Scholar
• Wang, D., D. Stravopodis, S. Teglund, J. Kitazawa, and J. N. Ihle 1996. Naturally occurring dominant negative variants of Stat5. Mol. Cell. Biol. 16: 6141–6148.
   PubMedGoogle Scholar
• Wang, H. Y., W. E. Paul, and A. D. Keegan 1996. IL-4 function can be transferred to the IL-2 receptor by tyrosine containing sequences found in the IL-4 receptor alpha chain. Immunity 4: 113–121.
   PubMedGoogle Scholar
• Wang, H. Y., J. Zamorano, J. L. Yoerkie, W. E. Paul, and A. D. Keegan 1997. The IL-4 induced tyrosine phosphorylation of the insulin receptor substrate is dependent on Jak1 expression in human fibrosarcoma cells. J. Immunol. 158: 1037–1040.
   PubMedGoogle Scholar
• Yan, Y., J. Frisen, M.-H. Lee, J. Massague, and M. Barbacid 1997. Ablation of CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev. 11: 973–983.
   PubMed Web of Science ®Google Scholar
• Yu, C.-L., D. J. Meyer, G. S. Campbell, A. C. Larner, C. Carter-Su, J. Schwartz, and R. Jove 1995. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269: 81–83.
   PubMed Web of Science ®Google Scholar
• Zamorano, J., H. Y. Wang, L.-M. Wang, J. H. Pierce, and A. D. Keegan 1996. IL-4 protects cells from apoptosis via the insulin receptor substrate pathway and a second independent signaling pathway. J. Immunol. 157: 4926–4934.
   PubMedGoogle Scholar
• Zerfass-Thome, K., A. Schulze, W. Zwerschke, B. Vogt, K. Helin, J. Bartek, B. Henglein, and P. Jansen-Durr 1997. p27Kip1 blocks cyclin E-dependent transactivation of cyclin A gene expression. Mol. Cell. Biol. 17: 407–415.
   PubMedGoogle Scholar
• Zhang, P., N. J. Liegeois, C. Wong, M. Finegold, H. Hou, J. C. Thompson, A. Silverman, J. W. Harper, R. A. DePinho, and S. J. Elledge 1997. Altered cell differentiation and proliferation in mice lacking p57Kip2 indicates a role in Beckwith-Wiedemann syndrome. Nature 387: 151–158.
   PubMed Web of Science ®Google Scholar
• Zuber, C. E., J. P. Galizzi, N. Harada, I. Durand, and J. Banchereau 1990. Interleukin-4 receptors on human blood mononuclear cells. Cell. Immunol. 129: 329–340.
   PubMed Web of Science ®Google Scholar